Sublingual nitroglycerin used in routine tilt testing provokes a cardiac output-mediated vasovagal response
Janneke Gisolf, MSc*,*,
Berend E. Westerhof, MSc
,
Nynke van Dijk, MD
,
Karel H. Wesseling, MSc
,
Wouter Wieling, MD, PhD
and
John M. Karemaker, PhD*
* Department of Physiology, Academic Medical Center, Cardiovascular Research Institute, AmsterdamNetherlands
TNO-TPD-BMI, Academic Medical Center, Cardiovascular Research Institute, AmsterdamNetherlands
Department of Internal Medicine, Academic Medical Center, Cardiovascular Research Institute, Amsterdam, Netherlands
Finapres Medical Systems, Amsterdam, the Netherlands

View larger version (20K):
[in a new window]
|
Figure 1 Hemodynamic response to NTG during the 60° tilt test. At 0 min, nitroglycerine is administered. (A) mean arterial pressure (MAP); (B) stroke volume (SV); (C) cardiac output (CO); (D) systemic vascular resistance (SVR); (E) heart rate (HR); (F) baroreflex sensitivity (BRS). Circles = minute averages and SEM. Open circles = negative tilt test; solid circles = positive tilt test.
|
|

View larger version (17K):
[in a new window]
|
Figure 2 Computed trends of minute averages over 4 min immediately after nitroglycerine administration during 60° tilt test. (A) Slope of heart rate; (B) Slope of stroke volume. Open circles = negative tilt test; solid circles = positive tilt test. Bars indicate SEM.
|
|
Copyright © 2004 by the American College of Cardiology Foundation.